Valérie Dubois

Université Claude Bernard Lyon 1 — France

Medicine · Health Sciences

41h-index5.6kcitations261works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal Transplantation Outcomes and Treatments(72), Hematopoietic Stem Cell Transplantation(66), T-cell and B-cell Immunology(60), Immune Cell Function and Interaction(48), Transplantation: Methods and Outcomes(26)

Publications259 total

Dual inhibition of mTOR and calcineurin pathways mitigates missing self-induced NK cells-mediated microvascsular inflammation : Supplemental Data
Recherche Data Gouv France·2026Open Access
MVI Missing Self RAW Anonymised NanoString Data.tab
Recherche Data Gouv France·2026Open Access
sampleinfo.tab
Recherche Data Gouv France·2026Open Access
gene_counts.tab
Recherche Data Gouv France·2026Open Access
README.md
Recherche Data Gouv France·2026Open Access
Maîtrise du risque hémorragique en préopératoire chez les patients atteints de cancer bronchique sous antithrombotique : c’est dans la poche !
Le Pharmacien Clinicien·2025
Donor Characteristics Associated With Graft Loss and Delayed Graft Function in Very-Aged Kidney Donors: An Observational Multicentric Study
Transplant International·2025Open Access
HLA diversity is associated with TKI response and treatment‐free remission in chronic myeloid leukemia
HemaSphere·2025Open Access
Gestion des CPA HLA phénotypés à l’EFS Auvergne Rhône-Alpes : du donneur au receveur
Transfusion Clinique et Biologique·2025
Cutting-edge technologies for HLA typing in Côte d’Ivoire: the role of next-generation sequencing 3970
The Journal of Immunology·2025Open Access
Dynamics and risk factors for long term pediatric liver graft fibrosis progression according to protocol liver biopsies over a 30-years follow-up
Digestive and Liver Disease·2025
Guidelines From the French‐Speaking Society for Histocompatibility and Immunogenetics ( <scp>SFHI</scp> ) for Harmonisation of <scp>HLA</scp> Genotyping in Autoimmune Diseases, Drug Hypersensitivity and Pharmacogenetics
HLA·2025
Innate Immune Defence
2025
BK Virus: Beyond Nephropathy Metastatic BK Virus-Induced, Donor-Derived Bellini’s Carcinoma in a Kidney Allograft Recipient: Boosting Rejection to Treat the Cancer
Transplant International·2025Open Access
Donor HLA Class I Evolutionary Divergence and Late Allograft Rejection After Liver Transplantation in Children: An Emulated Target Trial
HLA·2025Open Access
Sélection de produits transfusionnels pour limiter l’immunisation HLA avant allogreffe de cellules souches hématopoïétiques avec donneur mismatch (SFGM-TC)
Bulletin du Cancer·2025· 1 cited
13. Donor-Specific Antibodies in Vascularized Composite Allotransplantation: a Multicenter Study.
Transplantation·2025
Chemotaxis overrides the killing response in alloreactive CTLs, providing vascular immune privilege during cellular rejection
Journal of Clinical Investigation·2025· 4 citedOpen Access
The impact of the Banff v-lesion on rejection classification and outcomes: Insights from a multicenter study
American Journal of Transplantation·2025· 4 citedOpen Access
Identification of the Novel <scp>HLA</scp> ‐ <scp>DRB1</scp> *07:60:02 Allele by Next‐Generation Sequencing
HLA·2025· 2 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Olivier Thaunat(18), Emmanuel Morélon(14), Maud Rabeyrin(8), Jean‐Luc Taupin(7), Machteld Oudshoorn(6), Jean Villard(6), Mari Malkki(5), Mary M. Horowitz(5), J. Alejandro Madrigal(5), Yasuo Morishima(5), Stephen R. Spellman(5), Effie W. Petersdorf(5), A Sicard(5), Stéphanie Ducreux(5), Lionel Couzi(5), Pierre Merville(5), Katia Gagne(5), Dominique Charron(5), Alice Koenig(5), Maarten Naesens(5)